US 9616099
Cyclosporin analogues for preventing or treating hepatitis C infection
granted A61KA61K38/00A61K38/13
Quick answer
US patent 9616099 (Cyclosporin analogues for preventing or treating hepatitis C infection) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/00, A61K38/13, A61K38/21, A61K45/06